Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Stellari (Parma, Pr, Italy). CHF 6001 inhibits nuclear translocation of NF-?B in LPS-induced lung inflammation in mice. 1040

Member's Comments

No comment yet.

Related content which might interest you: A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004 Effect of curcumin on LPS-induced neutrophil activation and acute lung injury Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Dexamethasone reduces lung inflammation induced by alveolar stretch in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Kallistatin protects against LPS-induced mouse lung injury Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Upregulated of NO-synthesising lung activity and its correction in LPS-induced lung injury in mice Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004 Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005 Dexamethasone inhibits LPS-induced expression of human β-defensin-2 via down-regulation of TLR4 Source: Eur Respir J 2003; 22: Suppl. 45, 562s Year: 2003 Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Resolvin D1 attenuates lung inflammation in LPS induced-ALI partly through PPARγ/NF-κB pathway Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Remifentanil attenuates LPS-induced neutrophil activation Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012